Michael L. Goris

Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma.

Susan J. Knox, Michael L. Goris, Kirk Trisler et al. · PubMed · 1996 · 332 citations

Pharmacy, Hematology, Oncology +17

Efficacy and Safety of Tositumomab and Iodine-131 Tositumomab (Bexxar) in B-Cell Lymphoma, Progressive After Rituximab

Sandra J. Horning, Anas Younes, Vinay Jain et al. · Journal of Clinical Oncology · 2004 · 259 citations

Medicine, Hematology, Oncology +17

Therapeutic lymphangiogenesis with human recombinant VEGF‐C

Andrzej Szuba, Mihaela Skobe, Marika J. Karkkainen et al. · The FASEB Journal · 2002 · 257 citations

Medicine, Otolaryngology, Surgery +17

Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.

SJ Knox, Michael L. Goris, Margaret A. Tempero et al. · PubMed · 2000 · 212 citations

Medicine, Oncology, Pharmacology +12

Interpolative background subtraction.

Michael L. Goris, Sharon G. Daspit, Peter McLaughlin et al. · PubMed · 1976 · 201 citations

Medicine, Nuclear Medicine, Radiology +12